What is the likelihood of a pulmonary embolism (PE) in a patient with a positive D-dimer (1.39 μg/mL FEU), normal oxygen saturation (SaO2 98% on room air), normotension (blood pressure 111/65 mmHg), normal heart rate (HR 74 beats per minute), normal respiratory rate (RR 16 breaths per minute), and normal body temperature (36.3 degrees Celsius)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Likelihood of Pulmonary Embolism with Positive D-dimer

A positive D-dimer of 1.39 μg/mL FEU in isolation cannot confirm or exclude PE, as D-dimer has poor positive predictive value and must be interpreted in the context of clinical probability—your next step is to calculate a Wells or Geneva score to determine pretest probability, then proceed to CT pulmonary angiography (CTPA) if the score indicates intermediate or high probability. 1

Understanding D-dimer Limitations

The positive D-dimer result you have does not establish a diagnosis of PE. D-dimer testing has high negative predictive value but very low positive predictive value—it is useful only for ruling out PE, not confirming it. 1 The specificity of D-dimer is poor, meaning many conditions besides PE cause elevation, including cancer, hospitalization, infection, inflammation, and pregnancy. 1

Clinical Probability Assessment is Mandatory

Your patient's vital signs are reassuring (normal oxygen saturation 98%, normal heart rate 74 bpm, normal blood pressure, normal respiratory rate, normal temperature), which suggests they may have low clinical probability. However, you must formally calculate either a Wells score or revised Geneva score to stratify pretest probability before determining the likelihood of PE. 1, 2

Key Clinical Variables to Assess

For the revised Geneva score, assign points for: 1

  • Previous PE or DVT (1 point simplified version)
  • Heart rate 75-94 bpm (1 point) or ≥95 bpm (2 points)—your patient has HR 74, so 0 points
  • Recent surgery or fracture within past month (1 point)
  • Hemoptysis (1 point)
  • Active cancer (1 point)
  • Unilateral lower-limb pain (1 point)
  • Pain on deep venous palpation with unilateral edema (1 point)
  • Age >65 years (1 point)

Interpreting Clinical Probability

Regardless of which score you use, the proportion of patients with confirmed PE is approximately 10% in low-probability, 30% in intermediate-probability, and 65% in high-probability categories. 1 Using the two-level classification, PE prevalence is 12% in PE-unlikely and 30% in PE-likely categories. 1

Your Patient's PERC Status

Your patient fails PERC criteria because they do not meet all eight required criteria—specifically, the positive D-dimer itself indicates PERC cannot be applied retrospectively. 1, 2 PERC is designed to avoid D-dimer testing altogether in very low-risk patients, not to interpret results after testing. 1, 2

Next Steps Based on Clinical Probability

If Low or Intermediate Clinical Probability

With a positive D-dimer and low-to-intermediate clinical probability, proceed directly to CTPA, which has sensitivity of 83% and specificity of 96%. 1, 2 The elevated D-dimer (1.39 μg/mL is above the standard 0.5 μg/mL cutoff) mandates imaging in this context. 1

If High Clinical Probability

If your clinical assessment yields high probability, proceed immediately to CTPA without relying on the D-dimer result, as imaging is required regardless. 2, 3 In high-probability patients, even a negative D-dimer would not obviate the need for imaging. 2, 3

Age-Adjusted D-dimer Consideration

If your patient is >50 years old, note that age-adjusted D-dimer cutoffs (age × 10 ng/mL) improve specificity while maintaining sensitivity >97%. 1, 3 However, since your patient's D-dimer of 1390 ng/mL (1.39 μg/mL FEU) would exceed even an age-adjusted cutoff for patients up to age 139, this distinction is academic in this case—the D-dimer is definitively elevated. 3

Critical Pitfalls to Avoid

  • Do not use D-dimer alone to estimate PE likelihood—it requires clinical probability assessment for interpretation. 1
  • Do not assume normal vital signs exclude PE—approximately 30% of patients with intermediate clinical probability have PE despite reassuring vital signs. 1
  • Do not delay imaging while waiting for additional tests if clinical probability is intermediate or high with positive D-dimer. 2
  • Do not assume the patient is low-risk based solely on normal oxygen saturation—PE can be present with normal SaO2, especially in younger patients without underlying cardiopulmonary disease. 1

Quantifying the Actual Likelihood

Without knowing your patient's complete clinical picture (history of prior VTE, recent surgery, cancer status, leg symptoms, hemoptysis), the likelihood of PE ranges from 12% (if PE-unlikely by formal scoring) to 30% (if PE-likely) to potentially 65% (if high clinical probability). 1 The normal vital signs and oxygen saturation suggest lower probability, but formal scoring is essential. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Age-Adjusted D-Dimer Testing for Pulmonary Embolism Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What to do with an elevated D-dimer (D-dimer) level in a patient without any clinical suspicion of pulmonary embolism (PE)?
Is a CT angiography (CTA) pulmonary feasible for a large patient with an elevated D-dimer level to rule out a pulmonary embolism (PE)?
How critical is it to order a D-dimer (D-dimer test) to rule out pulmonary embolism (PE) in a 28-year-old female with Nexplanon (etonogestrel implant) and intermittent shortness of breath with activity, who has shown improvement with Flonase (fluticasone propionate) for suspected allergic rhinitis?
What is the acute treatment for a patient with a suspected pulmonary embolism (PE) and a positive D-dimer?
What are the management options for a patient with a positive D-dimer (D-dimer test) and positive chest Computed Tomography (CT) scan indicating a high risk for thromboembolic events, such as pulmonary embolism?
How to manage a patient with hypothyroidism and elevated TSH of 14.7 on Synthroid (levothyroxine) 50mg PO daily?
What is the approach to managing a patient with hyponatremia?
What cardiac symptoms should be monitored in a patient with hypothyroidism, pre-existing cardiac disease, and elevated Thyroid-Stimulating Hormone (TSH), taking Synthroid (levothyroxine)?
Is it safe to administer allergy shots (subcutaneous immunotherapy) at home for a patient on a tapering down dosing regimen?
How to manage a patient with non-specific unilateral lymphadenopathy (lymph node enlargement)?
How do I explain to a patient with hypothyroidism and pre-existing cardiac disease the reason for increasing their levothyroxine (T4) dose from 50mcg to 75mcg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.